A61K8/66

Cosmetic composition for improving appearance of scars
20230233433 · 2023-07-27 ·

A cosmetic composition for topical skin application and for use in reducing the appearance of scars comprising a combination of arginine and glutamine. The composition comprises L-Arginine in combination for L-Glutamine and further comprises bromelain, tetrahydrobisdemethoxydiferuloylmethane and tetrahydrocurcumin. Additional ingredients include various antioxidants, moisturizers, skin protectants, and vitamins together to promote the healing of affected skin while reducing visible scarring.

Cosmetic composition for improving appearance of scars
20230233433 · 2023-07-27 ·

A cosmetic composition for topical skin application and for use in reducing the appearance of scars comprising a combination of arginine and glutamine. The composition comprises L-Arginine in combination for L-Glutamine and further comprises bromelain, tetrahydrobisdemethoxydiferuloylmethane and tetrahydrocurcumin. Additional ingredients include various antioxidants, moisturizers, skin protectants, and vitamins together to promote the healing of affected skin while reducing visible scarring.

TREATMENT OF MODERATE TO VERY SEVERE GLABELLAR LINES AND LATERAL CANTHAL LINES

Disclosed herein are methods of treatment of glabellar lines and lateral canthal lines using liquid botulinum neurotoxin compositions.

TREATMENT OF MODERATE TO VERY SEVERE GLABELLAR LINES AND LATERAL CANTHAL LINES

Disclosed herein are methods of treatment of glabellar lines and lateral canthal lines using liquid botulinum neurotoxin compositions.

Mineralization agent and mouth wash comprising the same

A mineralization agent, including, by weight: 5-50% of a film-forming protein, 5-40% of an amelogenin peptide, 5-30% of a water-soluble phosphate, 4-20% of a tris(2-carboxyethyl) phosphine hydrochloride, and 1-10% of a pH regulator. The film-forming protein is selected from the group consisting of lysozyme, bovine serum protein, insulin, α-lactalbumin, or a mixture thereof.

Mineralization agent and mouth wash comprising the same

A mineralization agent, including, by weight: 5-50% of a film-forming protein, 5-40% of an amelogenin peptide, 5-30% of a water-soluble phosphate, 4-20% of a tris(2-carboxyethyl) phosphine hydrochloride, and 1-10% of a pH regulator. The film-forming protein is selected from the group consisting of lysozyme, bovine serum protein, insulin, α-lactalbumin, or a mixture thereof.

Skincare Composition and Process for Creating Sulforaphane
20230210760 · 2023-07-06 ·

A skincare composition includes a substance having a predetermined amount of one or more cruciferous vegetables, the predetermined amount of the one or more cruciferous vegetables including stabilized glucoraphanin and active myrosinase in a stable state; exposing the substance to a liquid activator causes a chemical reaction between the stabilized glucoraphanin and the active myrosinase to create sulforaphane in an active product; and applying the activated product to a skin surface allows the sulforaphane to act upon the skin surface.

Removal of biological deposits
11540994 · 2023-01-03 ·

Provided herein is a method of at least partly removing a biological deposit, such as a dag, from the skin of an animal. The method includes administering to the biological deposit an effective amount of a composition containing a keratinase, and optionally one or both of a reducing agent and a surfactant. Also provided is a composition for use in the aforementioned method as well as a method of making same.

Removal of biological deposits
11540994 · 2023-01-03 ·

Provided herein is a method of at least partly removing a biological deposit, such as a dag, from the skin of an animal. The method includes administering to the biological deposit an effective amount of a composition containing a keratinase, and optionally one or both of a reducing agent and a surfactant. Also provided is a composition for use in the aforementioned method as well as a method of making same.

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT CELLULITE
20220409511 · 2022-12-29 ·

The present disclosure provides a method of treating cellulite in a subject in need thereof by administering a composition that comprises a protein having hyaluronidase activity to a region of skin having cellulite on the subject. Also provided are methods of reducing the appearance of cellulite in a subject in need thereof comprising administering a composition that comprises a protein having hyaluronidase activity to a region of skin having cellulite on the subject, wherein the administration results in a reduction in a grade of severity of the cellulite.